Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.
Barr P.M., et al. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. Aug 2014 Vol 124:8.
PMID: 25016003
- Categories
- Abstracts
- Peer Reviewed Publications